Matches in SemOpenAlex for { <https://semopenalex.org/work/W4318539144> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W4318539144 endingPage "i950" @default.
- W4318539144 startingPage "i950" @default.
- W4318539144 abstract "Abstract Background Patients with inflammatory bowel disease (IBD) treated with immunomodulators or biological therapy are at increased risk of infections. Malnutrition and vitamin or mineral deficiencies are common among patients with IBD. The results of various studies have indicate that vitamin deficiencies might increase the risk of infections. Methods Single-centre, randomized, double-blinded, placebo-controlled clinical trial to compare a multivitamin and mineral supplement (vitamin group) versus identical in appearance placebo (placebo group). Patients with Crohn’s disease or ulcerative colitis using immunomodulators and/or biological therapy without vitamin deficiency were considered for participation in our study. Participants were asked to take a daily multivitamin and mineral supplement or placebo and report the occurrence of infections during a 24 weeks period of follow up. The primary endpoint of this study was the difference in incidence of infection between the two groups measured by a validated questionnaire, the revised version of the ID screen to assess infection13. Randomization was conducted by using computer generated random numbers with an allocation ratio of 1:1 to vitamin supplement or placebo in blocks of 8 and stratified according to type of IBD.Results Between July 2020 and February 2021, 320 patients were randomized. Treatment arms consisted out of 162 and 158 for vitamin and placebo, respectively. Both groups showed similarity in patient characteristics. All patients were included in the intention-to -Treat (ITT), 265 patients in the per protocol (PP) (compliance >80%) analyses. For both groups, 107 patients reported an infection during the 24 weeks follow up period (Unadjusted Odds Ratio: 0.93 (95% confidence interval: 0.56-1.48). In the vitamin group, 32 patients received antibiotics for an infection compared with 21 patients in the placebo group (Unadjusted Odds Ratio: 1.61 (95% confidence interval: 0.88-2.93). 166 patients in the PP analysis reported an infection (Unadjusted Odds Ratio: 0.91 (95% confidence interval: 0.55-1.50), 23 reported a serious infection (Unadjusted Odds Ratio: 2.57 (95% confidence interval: 1.02 -6.46). None of the patients was hospitalized due to serious infection. Conclusion An over the counter multivitamin and mineral supplement did not reduce the risk of infection for patients with IBD in remission with immunomodulators and/or biological therapy." @default.
- W4318539144 created "2023-01-31" @default.
- W4318539144 creator A5005647755 @default.
- W4318539144 creator A5009550531 @default.
- W4318539144 creator A5020914141 @default.
- W4318539144 creator A5029080795 @default.
- W4318539144 creator A5050614817 @default.
- W4318539144 creator A5053246826 @default.
- W4318539144 creator A5066434298 @default.
- W4318539144 creator A5087365371 @default.
- W4318539144 date "2023-01-30" @default.
- W4318539144 modified "2023-10-14" @default.
- W4318539144 title "P816 The efficacy of an over the counter multivitamin and mineral supplement to prevent opportunistic infections in patients with inflammatory bowel disease in remission" @default.
- W4318539144 doi "https://doi.org/10.1093/ecco-jcc/jjac190.0946" @default.
- W4318539144 hasPublicationYear "2023" @default.
- W4318539144 type Work @default.
- W4318539144 citedByCount "0" @default.
- W4318539144 crossrefType "journal-article" @default.
- W4318539144 hasAuthorship W4318539144A5005647755 @default.
- W4318539144 hasAuthorship W4318539144A5009550531 @default.
- W4318539144 hasAuthorship W4318539144A5020914141 @default.
- W4318539144 hasAuthorship W4318539144A5029080795 @default.
- W4318539144 hasAuthorship W4318539144A5050614817 @default.
- W4318539144 hasAuthorship W4318539144A5053246826 @default.
- W4318539144 hasAuthorship W4318539144A5066434298 @default.
- W4318539144 hasAuthorship W4318539144A5087365371 @default.
- W4318539144 hasBestOaLocation W43185391441 @default.
- W4318539144 hasConcept C120665830 @default.
- W4318539144 hasConcept C121332964 @default.
- W4318539144 hasConcept C124490489 @default.
- W4318539144 hasConcept C126322002 @default.
- W4318539144 hasConcept C141071460 @default.
- W4318539144 hasConcept C142724271 @default.
- W4318539144 hasConcept C168563851 @default.
- W4318539144 hasConcept C202953159 @default.
- W4318539144 hasConcept C203092338 @default.
- W4318539144 hasConcept C204243189 @default.
- W4318539144 hasConcept C204787440 @default.
- W4318539144 hasConcept C27081682 @default.
- W4318539144 hasConcept C2776551950 @default.
- W4318539144 hasConcept C2776940978 @default.
- W4318539144 hasConcept C2778260677 @default.
- W4318539144 hasConcept C2779134260 @default.
- W4318539144 hasConcept C2780479503 @default.
- W4318539144 hasConcept C61511704 @default.
- W4318539144 hasConcept C71924100 @default.
- W4318539144 hasConcept C90924648 @default.
- W4318539144 hasConceptScore W4318539144C120665830 @default.
- W4318539144 hasConceptScore W4318539144C121332964 @default.
- W4318539144 hasConceptScore W4318539144C124490489 @default.
- W4318539144 hasConceptScore W4318539144C126322002 @default.
- W4318539144 hasConceptScore W4318539144C141071460 @default.
- W4318539144 hasConceptScore W4318539144C142724271 @default.
- W4318539144 hasConceptScore W4318539144C168563851 @default.
- W4318539144 hasConceptScore W4318539144C202953159 @default.
- W4318539144 hasConceptScore W4318539144C203092338 @default.
- W4318539144 hasConceptScore W4318539144C204243189 @default.
- W4318539144 hasConceptScore W4318539144C204787440 @default.
- W4318539144 hasConceptScore W4318539144C27081682 @default.
- W4318539144 hasConceptScore W4318539144C2776551950 @default.
- W4318539144 hasConceptScore W4318539144C2776940978 @default.
- W4318539144 hasConceptScore W4318539144C2778260677 @default.
- W4318539144 hasConceptScore W4318539144C2779134260 @default.
- W4318539144 hasConceptScore W4318539144C2780479503 @default.
- W4318539144 hasConceptScore W4318539144C61511704 @default.
- W4318539144 hasConceptScore W4318539144C71924100 @default.
- W4318539144 hasConceptScore W4318539144C90924648 @default.
- W4318539144 hasIssue "Supplement_1" @default.
- W4318539144 hasLocation W43185391441 @default.
- W4318539144 hasOpenAccess W4318539144 @default.
- W4318539144 hasPrimaryLocation W43185391441 @default.
- W4318539144 hasRelatedWork W1506122018 @default.
- W4318539144 hasRelatedWork W2069424104 @default.
- W4318539144 hasRelatedWork W2070285775 @default.
- W4318539144 hasRelatedWork W2113780394 @default.
- W4318539144 hasRelatedWork W2391106790 @default.
- W4318539144 hasRelatedWork W2408939568 @default.
- W4318539144 hasRelatedWork W2418837291 @default.
- W4318539144 hasRelatedWork W2584850773 @default.
- W4318539144 hasRelatedWork W2890098371 @default.
- W4318539144 hasRelatedWork W46359855 @default.
- W4318539144 hasVolume "17" @default.
- W4318539144 isParatext "false" @default.
- W4318539144 isRetracted "false" @default.
- W4318539144 workType "article" @default.